Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.

With 8.09% CAGR, Active Pharmaceutical Ingredients (API) Market Size Worth $262.54 Billion by 2030 | Vantage Market Research WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Active Pharmaceutical Ingredients Market achieved a valuation of $141.3 Billion in 2022 and is anticipated to exceed $262.54 Billion by 2030,...

Dipharma expands its Italian R&D Center to increase its analytical services The Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market. MILAN, Italy, April 04, 2023 (GLOBE NEWSWIRE) -- Dipharma...